Novocure (NVCR) Tops Q3 EPS by 1c

Novocure (NASDAQ: NVCR) reported Q3 EPS of ($0.25), $0.01 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $130.99 million versus the consensus estimate of $132.42 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.

You May Also Be Interested In

• MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
• AnaptysBio, Inc. (ANAB) Tops Q2 EPS by 524c
• CRH plc (CRH) PT Lowered to $135 at UBS, Buy Rating Maintained